| MUTATION | 5'UTR; +10 (-T) | ||
|---|---|---|---|
| AMINO ACID REPLACEMENT | None | ||
| TYPE OF BETA-THAL | beta+ (silent) | ||
| MECHANISM | A reduced level of beta-mRNA was detected | ||
| IDENTIFICATION | Amplification of the beta-globin gene; automated fluorescent DNA sequencing; dot-blot analysis with allele specific probes (ASO) | ||
| HEMATOLOGY IN HETEROZYGOTE(S) | Hb 14.5-15.0 g/dl; MCV 94-102 fl; MCH 30.6-33.3 pg; Hb A2 2.5-2.7%; Hb F <1% | ||
| HEMATOLOGY IN HOMOZYGOTE(S) | None | ||
| OCCURRENCE | In a Greek family | ||
| HAPLOTYPE | Not done | ||
| FOUND IN COMBINATION WITH ABNORMAL HB(S) | None | ||
| FOUND IN COMBINATION WITH BETA-THAL ALLELE(S) | The proband (F-73 years) was a compound heterozygote for this mutation and codon 39 (C->T); Hb 9.0 g/dl; MCV 83 fl; MCH 27 pg; Hb A2 4.8%; Hb F 5.8%; beta/alpha ratio 0.27; splenectomized; thalassemia intermedia | ||
| OTHER INFORMATION | None |
| REFERENCES | |||
| 1. | Athanassiadou, A., Papachatzopoulou, A., Zoumbos, N., Maniatis, G.M., and Gibbs, R.: Br. J. Haematol., 88:307, 1994. | ||